» Articles » PMID: 39597752

Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Nov 27
PMID 39597752
Authors
Affiliations
Soon will be listed here.
Abstract

The historical and ongoing impacts of the influence of colonization are experienced by Indigenous people in systemic racism, inequity in healthcare access, and intergenerational trauma; originating in the disruption of a way of life and seen in a grief response, with links to disparate hepatitis C virus (HCV) prevalence. Despite this, the focus often remains on the increased incidence without a strengths-based lens. Although HCV is a global concern that can result in cirrhosis, liver failure, or cancer, diagnosing and linking people to care and treatment early can prevent advanced liver disease. Efforts to engage certain priority populations are occurring; however, historical context and current practices are often forgotten or overlooked. This is especially true with respect to Indigenous people in Canada. This review considers the published literature to elucidate the context of historical and ongoing colonizing impacts seen in the current HCV treatment gaps experienced by Indigenous people in Canada. In addition, we highlight strengths-based and Indigenous-led initiatives and programming that inspire hopefulness and steps toward community-engaged solutions to meet the World Health Organization Goals of eliminating HCV as a public health threat.

References
1.
Laugi H . Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine. Euroasian J Hepatogastroenterol. 2021; 10(2):105-108. PMC: 7801885. DOI: 10.5005/jp-journals-10018-1326. View

2.
Bruce V, Eldredge J, Leyva Y, Mera J, English K, Page K . Hepatitis C Virus Infection in Indigenous Populations in the United States and Canada. Epidemiol Rev. 2019; 41(1):158-167. PMC: 7305812. DOI: 10.1093/epirev/mxz015. View

3.
Parmar P, Corsi D, Cooper C . Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal. Can J Gastroenterol Hepatol. 2016; 2016:8987976. PMC: 4904644. DOI: 10.1155/2016/8987976. View

4.
Lepage C, Garber G, Corrin R, Galanakis C, Leonard L, Cooper C . Telemedicine successfully engages marginalized rural hepatitis C patients in curative care. J Assoc Med Microbiol Infect Dis Can. 2022; 5(2):87-97. PMC: 9602883. DOI: 10.3138/jammi-2019-0025. View

5.
Biondi M, Feld J . Hepatitis C models of care: approaches to elimination. Can Liver J. 2022; 3(2):165-176. PMC: 9202783. DOI: 10.3138/canlivj.2019-0002. View